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Abstract
Background: Oxidative stress is the major etiopathological factor in adriamycin-induced
cardiotoxicity. Relatively low amounts of endogenous antioxidant makes the heart vulnerable to
oxidative stress-induced damage. Chronic oral administration of garlic has been reported to
enhance the endogenous antioxidants of heart. We hypothesized that garlic-induced enhanced
cardiac antioxidants may offer protection against acute adriamycin-induced cardiotoxicity.
Results: Rats were either administered freshly prepared garlic homogenate (250 and 500 mg/kg
daily, orally, for 30 days) or probucol (cumulative dose, 120 mg/kg body weight divided in 12, i.p.
over a period of 30 days) or double distilled water (vehicle), followed by a single dose of adriamycin
(30 mg/kg i.p.). In the adriamycin group, increased oxidative stress was evidenced by a significant
increase in myocardial TBARS (thiobarbituric acid reactive substances) and decrease in myocardial
SOD (superoxide dismutase), catalase and GPx (glutathione peroxidase) activity. Histopathological
studies showed focal as well as subendocardial myocytolysis with infiltration of macrophages,
lymphocytes and edema. Immunocytochemistry showed marked expression of TNF-α (tumor
necrosis factor-alpha) in the myocardium. Increase in myocardial TBARS and decrease in
endogenous antioxidants by adriamycin was prevented significantly in the garlic treated rat hearts,
which was comparable to the probucol-treated group. Histopathological evidence of protection
was also evident in both garlic-treated and probucol-treated groups. Probucol, 250 mg/kg and 500
mg/kg of garlic reduced adriamycin induced TNF-α expression in the myocardium and was
associated with reduced myocyte injury.
Conclusions: It is concluded that chronic garlic administration prevents acute adriamycin-induced
cardiotoxicity and decreases myocardial TNF-α expression.
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Adriamycin, an anthracycline antibiotic, is widely used in
the treatment of a variety of human malignancies, includ-
ing breast cancer, small cell carcinoma of the lung and
acute leukemia's [1]. Like most of the anticancer drugs,
adriamycin also causes various toxic effects, the common-
est of which is the dose-dependent cardiotoxicity which
leads to acute and chronic heart failure [2].
Cellular damage induced by adriamycin is mediated by
the formation of an iron-anthracycline complex that gen-
erates free radicals, which, in turn, causes severe damage
to the plasma membrane and interferes with the cytoskel-
etal structure [3]. Due to the presence of a less developed
antioxidant defense mechanism, heart is particularly vul-
nerable to injury by anthracycline-induced reactive oxy-
gen species [4]. Considerable efforts have been made on
using antioxidants and iron-chelators to protect the heart
against adriamycin toxicity. Initial attempts to use tradi-
tional antioxidants, like N-acetylcystiene [5], tocopherol
[6] in the prevention of adriamycin-induced cardiotoxic-
ity were not very successful. Dexrazoxane, the only drug
presently approved by FDA to prevent adriamycin-
induced cardiotoxicity, is an iron chelator and possesses
potent antioxidant properties. But, due to the high inci-
dence of dexrazoxane-induced myelosuppression, its use
has also been limited to some advanced stages of malig-
nant disorders [7].
Therapeutic strategies, designed to augment cellular
endogenous defense systems have been identified as a
promising approach to combat oxidative stress-associated
disease conditions [8,9]. In this respect, probucol, a lipid-
lowering agent, which augments endogenous antioxi-
dants, has been shown to offer protection [10] in prevent-
ing adriamycin induced cardiotoxicity. Garlic, well known
for its medicinal use since ancient times, has been
reported to have antioxidant properties in vitro [11].
Recently, it has been shown that chronic intake of garlic
enhanced SOD and catalase in rat heart and shown pro-
tection against oxidative stress induced by ischemic reper-
fusion injury [12,13].
Oxidative stress-induced cardiotoxicity is mostly medi-
ated through expression of different cytokines, especially
TNF-α [14,15]. TNF-α has been implicated in the patho-
genesis of heart failure of varied etiology [14]. Modula-
tion of TNF-α expression constitutes an attractive
therapeutic option in such conditions. Substances, which
can inhibit TNF-α expression in oxidative stress-induced
cardiotoxicity, have potential therapeutic value.
In view of these facts the present study was designed to test
the hypothesis whether a nutritional strategy like chronic
garlic administration could prevent adriamycin-induced
acute cardiotoxicity, in terms of oxidative stress, expres-




There was significant (p < 0.01) increase in myocardial
TBARS in the ADR group (328.72 ± 34.76 nmol/gm wt)
when compared to the control (CTR) group (203.03 ±
11.52 nmol/gm wt). Significant decrease in the level of
myocardial TBARS was observed in PRO+ADR (p <
0.001), G-250+ADR (p < 0.001) and G-500+ADR (p <
0.02) groups (145.16 ± 13.13; 103.40 ± 17.24 & 276.54 ±
19.60 nmol/gm wt respectively) in comparison to the
ADR group.
Myocardial GSH
Significant (p < 0.001) increase in myocardial GSH was
observed in the ADR group (688.02 ± 12.17 µg/gm wt.) in
comparison to the control (CTR) group (479.17 ± 40.76
µg/gm wt.). In the groups PRO+ADR (p < 0.001), G-
250+ADR (p < 0.001) and G-500+ADR (p < 0.01), there
were significant decrease of myocardial GSH (507.46 ±
17.40; 447.59 ± 18.55 & 629.52 ± 11.37 µg/gm wt. respec-
tively) when compared to ADR group.
Table 1: TBA-RS, GSH, catalase, SOD and GPx in rat heart in different treatment groups
Group TBA-RS (n mole/
gm wet wt.)








CTR 203.03 ± 11.52 479.17 ± 40.76 49.49 ± 2.91 6.88 ± 0.79 0.193 ± 0.04
ADR 328.72 ± 34.76ab 688.02 ± 12.17ac 13.81 ± 3.70ac 4.54 ± 0.53aa 0.083 ± 0.002aa
PRO+ADR 145.16 ± 13.13d 507.46 ± 17.40d 14.76 ± 1.99 6.21 ± 0.79 0.158 ± 0.03a
G-250+ADR 103.40 ± 17.24d 447.59 ± 18.55d 25.12 ± 3.33d 6.08 ± 1.72 0.149 ± 0.03a
G-500+ADR 276.54 ± 19.60b 629.52 ± 11.37c 15.41 ± 3.21 7.61 ± 0.93b 0.177 ± 0.01d
All values are expressed as Mean ± SE (n = 6). p values: a < 0.05, b < 0.02, c < 0.01, d < 0.001 vs ADR and aa < 0.05, ab < 0.01, ac < 0.001 vs CTR. 
(One way ANOVA)Page 2 of 9
(page number not for citation purposes)
BMC Pharmacology 2003, 3 http://www.biomedcentral.com/1471-2210/3/16Myocardial Catalase
In the ADR group (13.81 ± 3.70 U/mg protein) there was
a significant (p < 0.001) decrease in myocardial catalase
compared to control (CTR) group (49.49 ± 2.91 U/mg
protein). In the group PRO+ADR (14.76 ± 1.99 U/mg pro-
tein), there was no significant increase in the level of myo-
cardial catalase compared to ADR group. However,
significant (p < 0.001) increase in myocardial catalase
level was seen only in group G-250+ADR (25.12 ± 3.33 U/
mg protein) but not in group G-500+ADR (15.41 ± 3.21
U/mg protein).
Myocardial SOD
In ADR group (4.54 ± 0.53 U/mg protein), there was a sig-
nificant (p < 0.05) reduction of myocardial SOD level
when compared to control (CTR) group (6.88 ± 0.79 U/
mg protein). There were no increase in the level of myo-
cardial SOD in PRO+ADR and G-250+ADR groups (6.21
± 0.79 & 6.08 ± 1.72 U/mg protein respectively) when
compared to ADR group. But significant (p < 0.02)
increase in SOD was observed in G-500+ADR group (7.61
± 0.93 U/mg protein).
Myocardial GPx
Significant (p < 0.05) reduction of GPx activity was
observed in ADR group (0.083 ± 0.002 U/mg protein)
when compared to control (CTR) group (0.193 ± 0.04 U/
mg protein). Increased of the GPx activity were observed
in all three groups, PRO+ADR (p < 0.05), G-250+ADR (p
< 0.05) and G-500+ADR (p < 0.001) (0.158 ± 0.03; 0.149
± 0.03 & 0.177 ± 0.01 U/mg protein respectively).
Heart weight : body weight ratio: (Table-2)
There was a significant (p < 0.05) decrease in the heart
weight : body weight ratio in the group ADR (5.78 ± 0.20,
1 × 10-3) compared to group CTR (6.25 ± 0.18, 1 × 10-3).
There was no significant fall in the heart weight : body
weight ratio in PRO+ADR, G-250+ADR and G-500+ADR
groups (6.15 ± 0.17; 6.13 ± 0.12 & 6.29 ± 0.13, 1 × 10-3)
compared to group ADR.
Histopathological changes
Marked tissue injury with subendocardial loss of muscles
and accumulation of acute inflammatory cells surrounded
by mild edema was seen in ADR group (Fig. 1A). In the
PRO+ADR group (Fig. 1B), only focal necrosis of muscle
fiber with moderate edema was noted. Multiple necrotic
foci with marked edema was seen in group G-250+ADR
(Fig. 1C), which was less in G-500+ADR group (Fig. 1D).
Myocardial TNF-α expressions: Table 3
There was no expression of TNF-α in any region of the
untreated control (CTR) rat hearts (score: 0, Fig. 2A)).
Intense (score: 4, Fig. 2B) TNF-α expression was seen in
the subendocardial region, myocardium and the blood
vessels in the adriamycin treated rat hearts (ADR group).
Probucol treatment (group PRO+ADR) caused a reduc-
tion of TNF-α expression (score: 1.6, Fig. 2E) in the myo-
cardium, endothelial region and blood vessels. Similarly,
in G-250+ADR and G-500+ADR groups, there was less
expression (score: 2.8, Fig. 2C and 2.9, Fig. 2D) of TNF-α
in the myocardium, blood vessels and subendocardial
region compared to ADR group. However, in the group G-
500+ADR, there was least TNF-α expression in the
myocardium.
Discussion
Adriamycin is converted into its semiquinone form in the
cardiac myocyte by myocardial CYP450 and flavin mon-
oxygenases. The semiquinone form is a toxic, short-lived
metabolite and interacts with molecular oxygen and initi-
ates a cascade of reaction, producing reactive oxygen spe-
cies (ROS) [24]. Another reported mechanism of
adriamycin-induced oxidative stress is the formation of an
anthracycline-iron (Fe2+) free radical complex [25]. The
latter reacts with hydrogen peroxide to produce hydroxyl
(OH•) radical. ROS react with lipids, protein and other
cellular constituents to cause damage to mitochondria
and cell membranes of the heart muscle cells.
In the present study, a single dose (30 mg/kg) of adriamy-
cin caused a significant increase in myocardial TBARS and
decrease in myocardial SOD, catalase and GPx activity
indicating an increase in oxidative stress. The increase in
myocardial GSH appears to be paradoxical, the mecha-
nism of which although not clear may be postulated. Due
to reduced GPx activity myocardial GSH can not be ade-
quately oxidized to GSSG, as part of its antioxidant
activity. As a result of which the level of GSH rises due to
"trapping" of glutathione in its reduced form.
Table 2: Heart Wt / Body Wt ratio: (1 × 10-3)
CTR ADR PRO+ADR G-250+ADR G-500+ADR
6.25 ± 0.18 5.78 ± 0.20 6.15 ± 0.17 6.13 ± 0.12 6.29 ± 0.13
All values are expressed as Mean ± SE (n = 6). p values: a < 0.05 vs CTR (Student's t-test)Page 3 of 9
(page number not for citation purposes)
BMC Pharmacology 2003, 3 http://www.biomedcentral.com/1471-2210/3/16Light micrograph of rat heartFi ure 1
Light micrograph of rat heart A] treated with adriamycin (ADR) showing subendocardial loss of muscles with inflammatory 
cells surrounded by edema (H&E × 10) B] treated with probucol and adriamycin (PRO+ADR) showing focal necrosis of mus-
cle fibre with mild edema (H&E, × 10) C] treated with garlic 250 mg/kg and adriamycin (G-250+ADR) showing multiple focci 
necrosis of cardiac muscle with marked edema (H&E, × 10) D] treated with garlic 500 mg/kg and adriamycin (G-500+ADR) 
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Heart section from a rat A] treated with normal saline (CTR) showing no expression of TNF-α in the myocardium (H&E, × 
10) B] treated with adriamycin (ADR) showing marked expression of TNF-α in the myocardium, blood vessels and the sub-
endocardial region (H&E, × 25) C] treated with garlic 250 mg/kg and adriamycin (G-250+ADR) showing occasional myocar-
dial and blood vessels expression of TNF-α (H&E, × 10) D] treated with garlic 500 mg/kg and adriamycin (G-500+ADR) 
showing only subendocardial TNF-α expression (H&E, × 25) E] treated with probucol and adriamycin (PRO+ADR) showing 
occasional TNF-α expression in the blood vessels as well as in the endocardium (H&E, × 10).
Table 3: TNF-α Expressions in the rat heart
GROUPS OVERALL SCORE SITE SPECIFIC EXPRESSION
Myocardium Blood vessels Subendocardium
CTR 0 - - -
ADR 4 +++ +++ +++
PRO+ADR 1.6 + ++ +
G-250+ADR 2.8 + ++ +
G-500+ADR 2.9 - + ++
-, Absent +, Light ++, Moderate +++, Intense
A B
C D
EPage 5 of 9
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weight / body weight ratio, which indicate loss of myofi-
brils and cytoplasmic vacuolisation in myocytes [26]. His-
topathological studies revealed loss of myofibrils,
subendocardial myocytolysis and vacuolization in the
adriamycin treated rat hearts. Similar observations have
also been made in earlier studies on acute adriamycin-
induced cardiotoxicity [27,28].
Increase in SOD and catalase activities in rat heart follow-
ing chronic garlic intake, as reported earlier by our group
[12], has a special significance, in relation to cellular
defense against oxidative stress. Previously, aged garlic
extract has been reported to prevent ADR-induced cardio-
toxicity through its direct antioxidant effect [29]. In this
regard, mechanism of cardioprotection by garlic in the
present study is novel.
The most abundant reactive oxygen species (ROS) gener-
ated in living cells are superoxide anion and its deriva-
tives, particularly highly reactive and damaging hydroxyl
radical, which induces peroxidation of cell membrane
lipid [30]. Lipid peroxidation is known to induce cellular
damage and is responsible for ROS induced organ damage
[31]. In this respect, any increase in SOD activity of the
organ appears to be beneficial in the event of increased
free radical generation. However, it has been reported that
a rise in SOD activity, without a concomitant rise in the
activity of catalase and/or GPx might be detrimental [32].
It is due to the fact that SOD generates hydrogen peroxide
as a metabolite, which is cytotoxic and has to be scav-
enged by catalase or GPx. Thus a simultaneous increase in
catalase and/or GPx activity is essential for an overall ben-
eficial effect of increase in SOD activity. Inhibition of adri-
amycin-induced oxidative stress and tissue injury might
be attributed to the increase in both myocardial SOD and
catalase activities, following chronic garlic
administration.
Increase in lipid peroxidation following acute adriamycin
administration, was significantly prevented by both the
doses of garlic and this effect was comparable with that of
probucol treatment. The improvement in myocardial
TBARS was much less with the higher dose than with the
lower dose. This can be explained by the fact that basal
TBARS value was higher after chronic garlic treatment in
500 mg/kg dose than 250 mg/kg dose [12]. The paradox-
ical rise in the level of reduced glutathione in adriamycin-
induced cardiotoxicity was blunted in garlic as well as
probucol treated hearts. This supports our hypothesis (as
mentioned before) of "trapping" of glutathione in its
reduced form (GSH) in ADR treated rat heart, which was
postulated to occur due to reduction in GPx activity. Rise
in GSH level was absent in garlic and ADR-treated rat
hearts due to prevention of reduction in myocardial GPx
activity. Significant preservation of myocardial catalase
and GPx activities was seen with 250 mg/kg dose of garlic,
whereas significant preservation of myocardial SOD and
GPx activities was seen in 500 mg/kg garlic treated group.
Although myocardial protection was observed in garlic
(250 and 500 mg/kg) and probucol treated groups, 500
mg/kg dose of garlic seems to be better as evident from the
histopathological studies supporting the earlier statement
of the significance of simultaneous increase in SOD and
GPx activity in mitigating oxidative stress.
Expression of various cytokines, especially that of TNF-α
is enhanced in various pathophysiological states, associ-
ated with increased oxidative stress [14,15], which in turn
promotes the induction of various other cytotoxic sub-
stances on endothelial cells and myocytes. This has pro-
found pathological significance, in terms of development
of cardiomyopathy, myocyte apoptosis, transmural myo-
carditis and biventricular fibrosis as well as overall func-
tional deterioration of heart [33,34]. Adriamycin, in our
study, caused marked TNF-α expression in the subendo-
cardial region, myocardial cells and intramyocardial ves-
sel wall. It is possible that increased oxidative stress
following adriamycin administration caused expression
of TNF-α. Oxidative stress is known to activate P38-
mitogen activated protein (MAP) kinase and nuclear fac-
tor kappa B and thus play a role in the sequence of signal-
ing events involved in myocardial TNF-α production
[35,36]. To the best of our knowledge, expression of TNF-
α in heart of ADR-treated rat is reported for the first time
in the present study. Probucol, as well as 250 mg/kg and
500 mg/kg of garlic treatment reduced the myocardial
expression of TNF-α, following adriamycin administra-
tion which was associated with reduced myocyte injury,
an effect which might be attributed to reduction in oxida-
tive stress.
Conclusions
It is concluded that garlic protects adriamycin-induced
acute cardiotoxicity by preservation of endogenous anti-
oxidant, reduction of lipid peroxidation and TNF-α
expression in rat heart. The study reveals the role of




The study has been approved by the Animal Care Ethics
Committee of Institute. Laboratory bred Wistar albino rats
of both sexes weighing between 150 gm and 200 gm,
maintained under standard laboratory conditions of 22 ±
2°C, relative humidity 50 ± 15% and photo period (12 hr
dark/12 hr light) were used for the experiment. Commer-
cial pellet diet and water were provided ad lib. Commer-
cial pellet diet (Hindustan Lever, India) contains protein:Page 6 of 9
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phosphorous: 0.3%, moisture:10% and ash:9% w/w.
Chemicals
Garlic was obtained from the local market. Adriamycin
was obtained from Dabur India Ltd. and probucol from
Sigma Chemicals Co., USA. All chemicals were of analyti-
cal grade and chemicals required for sensitive biochemical
assays were obtained from Sigma Chemical Co., USA.
Double distilled water was used in all biochemical assays.
Garlic homogenate preparation and doses
Garlic cloves were peeled, sliced, ground into a paste and
then made a homogenate in distilled water. Two doses of
garlic homogenate, 250 mg/kg (0.1 gm/ml) and 500 mg
mg/kg (0.2 gm/ml) were fed daily to the rats within 30
minutes of its preparation for a continuous period of 30
days. A control group of rats were fed only with standard
rat feed and double distilled water (the vehicle for the
extracts) and was maintained for the same period.
Experimental protocol
Rats were divided into five groups containing eight rat per
group. In the control group (CTR), rats were fed with dou-
ble distilled water. In the group ADR, adriamycin (30 mg/
kg single dose) was administered intraperitoneally.
Probucol (cumulative dose, 120 mg/kg body weight
divided in 12 equal injection over a period of 30 days) was
administered intraperitoneally followed by adriamycin
(30 mg/kg single dose) challenge in group PRO+ADR. In
case of groups G-250+ADR and G-500+ADR, adriamycin
(30 mg/kg single dose) was administered intraperito-
neally in the rats treated with 250 mg/kg and 500 mg/kg
garlic homogenate, respectively, after completion of their
30 days treatment. After 24 hours of adriamycin adminis-
tration the rats were heparinised (375 units/200 gms, i.p)
[16], sacrificed half an hour later with anaesthetic ether
and hearts, harvested for the following procedures.
Biochemical parameters
Myocardial lipid peroxidation [17]
Heart was homogenized in 10% trichloroacetic acid in
4°C. A 0.2 ml homogenate was pipetted into a test tube,
followed by the addition of 0.2 ml of 8.1% sodium
dodecyl sulphate (SDS), 1.5 ml of 30% acetic acid (pH-
3.5) and 1.5 ml of 0.8% TBA. Tubes were boiled for 60
min. at 95°C and then cooled on ice. 1.0 ml double dis-
tilled water and 5.0 ml of n-butanol:pyridine (15:1 v/v)
mixture were added to the tubes and centrifuged at 4000
× g for 10 minutes. The absorbance of the developed col-
our in organic layer was measured at 532 nm. Commer-
cially available 1,1,3,3-tetraethoxypropane (Sigma) was
used as a standard for MDA. TBARS are expressed as nmol/
gm wet wt.
Myocardial GSH [18]
Heart was homogenized with 10% TCA and centrifuged at
3000 × g for 10 minutes. The reaction mixture contained
0.1 ml of supernatant, 2.0 ml of 0.3 M phosphate buffer
(pH-8.4), 0.4 ml of double distilled water and 0.5 ml of
DTNB [5,5 dithiobis (2-nitrobenzoic acid)]. The reaction
mixture was incubated for 10 minutes and the absorbance
was measured at 412 nm. The level of GSH was deter-
mined from the standard curve with commercially availa-
ble GSH (Sigma chemical). GSH are expressed as µ mole
per gm wet weight.
Myocardial catalase [19]
Heart was homogenized at 4°C (1:10) in 50 mmole/l
potassium phosphate buffer (pH-7.4) and centrifuged at
3000 × g for 10 minutes. Supernatant (50 µl) was added
to a 3.0 ml cubette that contained 1.95 ml of 50 mM phos-
phate buffer (pH-7.0). 1.0 ml of 30 mM hydrogen perox-
ide was added to it and changes in absorbance were
followed for 30 sec. at 240 nm at an interval of 15 sec. Cat-
alase activity was expressed as units per mg protein.
Myocardial SOD [20]
Hearts was homogenised in 0.25 M tris sucrose buffer and
centifuged at 10,000 × g for 15 minutes at 4°C. The super-
natant was fractionated by 50% ammonium sulphate and
dialysed overnight. Aliquots of the supernatant (100 µl)
was added to sodium pyrophosphate buffer (pH-8.3) fol-
lowed by addition of 0.1 ml of 186 µM phenazine meth-
osulphate, 0.3 ml of 300 mM nitroblue tetrazolium and
0.2 ml of 780 µM NADH. Reaction mixture was incubated
for 90 second at 30°C and the reaction stopped by adding
1.0 ml of acetic acid. 4.0 ml of n-butanol was then added
and centrifuged at 3000 × g for 10 minutes. The
absorbance of organic layer was measured at 560 nm.
SOD is expressed as units per mg protein.
Myocardial GPx [21]
Heart was homogenized at 4°C in 0.25 M phosphate
buffer saline (pH-7.0). Homogenate was centrifuged at
15,000 × g for 60 min. at 4°C and supernatant was
assayed for the GPx activity. GPx activity was assayed in a
1.0 ml cubette containing 400 µl of 0.25 M potassium
phosphate buffer (pH-7.0), 200 µl of sample, 100 µl of 10
mM GSH, 100 µl 2.5 mM NADPH and 100 µl of glutath-
ione reductase (6 U/ml). The reaction was started by add-
ing 100 µl of 12 mM hydrogen peroxide and changes of
absorbance at 366 nm at 1 min interval for 5 min. were
measured. GPx activity are expressed as units per mg
protein.
Protein concentration is measured by Bradford method.Page 7 of 9
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Hearts were fixed in 10% formalin, processed and embed-
ded in paraffin. 3 µm. thick paraffin sections were cut on
glass slides and stained with hematoxylin and eosin
(H&E), periodic acid Schiff (PAS) reagent and examined
by light microscope to assess gross myocyte injury (adri-
amycin-induced) and the effects of the interventions.
Estimation of heart: body weight ratio
In each group, rats were taken for the estimation of heart
weight : body weight ratio [22]. Body weight was the
weight on the day of sacrifice. Heart weight was measured
after keeping the heart in cold saline and squeezing out
the blood.
Immunocytochemistry
Rats were sacrificed and hearts perfused with 10% forma-
lin and finally stored in 10% formalin at 4°C for paraffin
sectioning (N = 3). Five-micron-thick paraffin-embedded
sections were used for immuno-staining using an
immuno-enzymatic staining kit (DACCA PAP kit, system
40; DAKO). After deparafinization and hydration through
two changes of xylene and graded alcohol for 10 minutes
in each solution, tissue sections were incubated in a
humidified chamber with proteinase K (20 ug/ml; Sigma)
for 15 minutes at 23°C and washed in distilled water.
After washing in Tris-buffered saline (TBS; 0.05 mole/L
Tris, pH 7.4, 0.15 mol/L NaCl), endogenous peroxidase
activity was blocked by incubating for 5 minutes at 23°C
in 3% H2O2 in TBS, washed in TBS (four times for 2 min-
utes each), and incubated for 40 minutes at 23°C with
blocking solution (0.5% Tween 20 plus 0.5% BSA plus
10% normal goat serum, pre immune) to block nonspe-
cific binding. The sections were then incubated at 23°C
for 1 hour with rabbit anti-mouse TNF-α (2.0 ug/
ml)(Santa Cruz Biotechnology, Inc.), washed in TBST
(TBS plus 0.5% Tween 20) three times for 5 minutes each,
incubated at 23°C for an additional 20 minutes with sec-
ondary antibody (goat anti-rabbit; DAKO). After washing
in TBST 3 times for 5 minutes each, the sections were incu-
bated for 20 minutes at 23°C with soluble horseradish
peroxidase/rabbit anti-horseradish peroxidase complex
prediluted in TBS. The sections were then incubated with
3,3'-diaminobezidine tetrahydrochloride (DAKO liquid
DAB) as the substrate. Counter staining was then per-
formed with Mayer's hematoxylin (Fluka, Rankonkoma.
NY). After dehydration, cover slips were mounted on
slides in Permount (Sigma). Omission of primary anti-
body and use of rabbit pre immune serum in place of pri-
mary antibody after neutralization with its peptide
antigen (Santa Cruz Biotechnology) served as controls.
Immunocytochemical staining was evaluated by light
microscopy. Staining was assessed semiquantitatively as
the percentage of positively stained cells [23] according to
the following scale: 0 – no staining present. 1 – Very light
(1 – 10%) 2 – Light (10 – 30%) 3 – Moderate (30 – 70%)
4 – Intense (70 – 100%)
Five independent observers blinded to the groups studied
scored the sections and the average data presented a con-
sensus value of all observations.
Statistical Analysis
All values are expressed as mean ± SEM. One way ANOVA
was applied to test for significance of biochemical data of
different groups and Student's t-test was applied to test for
heart weight : body weight ratio. Significance was set at p
< 0.05.
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